Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile
Xavier Andrade-Gonzalez MD

@xavierandradeg

Hematologist with focus on hematological malignancies, BMT and Cellular Therapy |
Mayo Clinic Alumni | Tweets are my own.

ID: 494423013

calendar_today16-02-2012 21:56:34

149 Tweet

232 Takipçi

312 Takip Edilen

Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

Excelente presentacion del Servicio de Hematologia del #HospitalLuisVernaza en la reunion anual de la Sociedad Americana de Hematologia. Que orgullo! Felicitaciones! 👏Carlos Plaza, MD Brenner Sabando V. Alejandra Posligua

Excelente presentacion del Servicio de Hematologia del #HospitalLuisVernaza en la reunion anual de la Sociedad Americana de Hematologia. Que orgullo! Felicitaciones! 👏<a href="/CarlosPlazaM/">Carlos Plaza, MD</a> <a href="/BrennerSabando/">Brenner Sabando V.</a> <a href="/ALEPOSLI/">Alejandra Posligua</a>
Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile Photo

Very grateful to ASH for giving due recognition to #MDSMPN overlap syndromes| Several exciting papers #CMML #JMML #MDSMPNRST| Raphael Itzykson Dacota study- lack of benefit of HMA in #MPNCMML @MoritzBinderMD ssRNA ssATAC in #ASXL1mtCMML Mayo Clinic Center for Individualized Medicine

Very grateful to <a href="/ASH_hematology/">ASH</a> for giving due recognition to #MDSMPN overlap syndromes| Several exciting papers #CMML #JMML #MDSMPNRST| <a href="/raphaelitzykson/">Raphael Itzykson</a> Dacota study- lack of benefit of HMA in #MPNCMML @MoritzBinderMD ssRNA ssATAC in #ASXL1mtCMML <a href="/MayoClinicCIM/">Mayo Clinic Center for Individualized Medicine</a>
Jonathan Friedberg (@drjfriedberg) 's Twitter Profile Photo

Max Topp: Great scientific session on bispecific antiCD20’s #ASH2020 CRs reported post CAR-T. Several exciting options, in indolent and aggressive lymphomas.

Max Topp: Great scientific session on bispecific antiCD20’s #ASH2020   CRs reported post CAR-T. Several exciting options, in indolent and aggressive lymphomas.
Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

Excellent presentation covering challenging situations in patients with DLBCL. Glad to see "real world" scenarios covered. That said, we still need to improve our standarized tools to assess fitness. #ASH20 #DLBCL

Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

Outstanding poster by Antoine Saliba on hematologic immune-related adverse events in patients on ICI therapy. Median time-to-irAE: 18 days. AIHA most common (41%). 53% responded to steroids alone, 33% need additional Rx. Carefully select pts. to rechallenge. #ASH20

Outstanding poster by <a href="/AntoineNSaliba/">Antoine Saliba</a> on hematologic immune-related adverse events in patients on ICI therapy. 

Median time-to-irAE: 18 days. AIHA most common (41%). 53% responded to steroids alone, 33% need additional Rx. Carefully select pts. to rechallenge. 

#ASH20
Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

Interesting work by @UDurani. COVID-19 ⬆️burnout (BO) on hem-onc trainees. Highest risk was pre-existing BO. Interestingly, preCOVID burnout prevalence was 22%!! Maybe the pandemic just highlighted a bigger problem here.. #MedEd #ASH20 #ASHKudos

Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

Honored to present our findings. Ferritin as a simple, widely available test to enhance pre-alloSCT risk-stratification tools in patients with MF. #ASH20 #Allosct #myelofibrosis #mpnsm

Jorge G. Ortiz-Garcia, MD, MSCR, FAAN (@jorge_ortiz_g) 's Twitter Profile Photo

NINDS trial was published 25 years ago. The t-PA revolutioned the stroke treatment. A Milestone in the history of Neurology. Today, t-PA is used with or without mechanical thrombectomy. Stroke is more treatable than ever, but time is crucial, “TIME IS BRAIN” #Neurology #Stroke

NINDS trial was published 25 years ago. The t-PA revolutioned the stroke treatment. A Milestone in the history of Neurology. Today, t-PA is used with or without mechanical thrombectomy. Stroke is more treatable than ever, but time is crucial, “TIME IS BRAIN” #Neurology #Stroke
Xavier Andrade-Gonzalez MD (@xavierandradeg) 's Twitter Profile Photo

No hay palabras... qué grande Barcelona! Campeón y vuelta olímpica donde hace años se merecía. Aunque apaguen las luces, fue la noche donde brilló el sol... Salud Campeón ⚽️🏆

No hay palabras... qué grande Barcelona! Campeón y vuelta olímpica donde hace años se merecía. Aunque apaguen las luces, fue la noche donde brilló el sol... Salud Campeón ⚽️🏆
Jorge G. Ortiz-Garcia, MD, MSCR, FAAN (@jorge_ortiz_g) 's Twitter Profile Photo

Un gusto compartir con los estudiantes de la @ucatolicagye en este Primer Curso Virtual de Neurología. Gracias a Rocío Santibáñez Vásquez 🇪🇨 por la organización. Un honor compartir conferencias con dos grandes colegas y amigos Victor J. Del Brutto, MD, MSc y Patricio Valle . . #Neurologia #Neurocirugia

Un gusto compartir con los estudiantes de la <a href="/ucatolicagye/">@ucatolicagye</a> en este Primer Curso Virtual de Neurología. Gracias a <a href="/neurologiagye/">Rocío Santibáñez Vásquez 🇪🇨</a> por la organización. Un honor compartir conferencias con dos grandes colegas y amigos <a href="/vdelbrutto/">Victor J. Del Brutto, MD, MSc</a> y Patricio Valle  
.
.
#Neurologia #Neurocirugia
Ohio State Hematology (@osuhematology) 's Twitter Profile Photo

Excited to announce that Evandro Bezerra will be joining the The James team this summer from the Mayo Clinic in our #BMT and #CellularTherapy program. We're thrilled to bring his expertise and clinical care to The Ohio State University Wexner Medical Center Pelotonia

Excited to announce that <a href="/E_D_Bezerra/">Evandro Bezerra</a> will be joining the <a href="/OSUCCC_James/">The James</a> team this summer from the Mayo Clinic in our #BMT and #CellularTherapy program.

We're thrilled to bring his expertise and clinical care to <a href="/osuwexmed/">The Ohio State University Wexner Medical Center</a> <a href="/Pelotonia/">Pelotonia</a>
Aaron Goodman - “Papa Heme” (@aarongoodman33) 's Twitter Profile Photo

Your daily inspiration I am clinical educator NOT a lead clinical trialist researcher well known with elites of oncology (or liked) However, using Twitter,asking tough questions, sharing what I find educational I have created numerous opportunities for myself You can too!